Overview

Endo International plc is a highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA.
DateTitle 
04/25/17Endo to Announce First-Quarter 2017 Financial ResultsPrinter Friendly Version
04/12/17Endo International plc Announces Pricing of Private Offering of Senior Secured NotesPrinter Friendly Version
04/10/17Endo International plc Announces Proposed Private Offering of Senior Secured NotesPrinter Friendly Version
04/05/17Endo International plc Announces Plan to Refinance Existing Credit AgreementPrinter Friendly Version
What's New
DateTitle
04/28/17
Download Documentation 2016 Annual Report
04/11/17
Download Documentation Corporate Fact Sheet
01/09/17
Download Documentation J.P. Morgan Healthcare Conference Presentation – January 9, 2017
11/08/16
Download Documentation Final ENDP Q3 2016 Slides
Get help downloading or viewing the above file types

Investor Relations / Media Contact:
Stephen Mock
Senior Vice President, Investor Relations and Corporate Affairs
845-364-4833
Email: mock.stephen@endo.com

Investors Relations Contact:
Nina Goworek
Senior Director, Investor Relations
484-216-6657
Email: goworek.nina@endo.com  

Media Contact:
Heather Zoumas-Lubeski
Senior Director,
Corporate Affairs
484-216-6829
Email: zoumaslubeski.heather@endo.com

Receive E-mail AlertsE-mail Alert Icon
You may automatically receive Endo Pharmaceuticals news and financial information by email. To choose your options for email notification, please enter your email address below and click Submit. To change your email options at any time, re-enter your email address and click Submit, then adjust your form entries.
Print Page Print Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts